ENOV compared with IART: revenue, margins and what each company keeps, and the suppliers and customers both name

ENOVEnovis Corp

Mkt capRevenueRevenue

IARTIntegra Lifesciences Holdings Corp

Mkt capRevenueRevenue

Compare

ENOVEnovis Corp

IARTIntegra Lifesciences Holdings Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ENOVEnovis Corp

19.98· pre 19.98· delayed

Mkt cap$1.1BRevenue$583MQ2 FY26Revenue$2.2BFY25

IARTIntegra Lifesciences Holdings Corp

12.74· pre 12.74· delayed

Pre-marketOct 30 '26delayed

Mkt cap$992.0MRevenue$411MQ3 FY26Revenue$1.6BFY25

Compare

Pre-marketOct 30 '26delayed

ENOVEnovis Corp

IARTIntegra Lifesciences Holdings Corp

19.98pre 19.98delayed

Price

12.74pre 12.74delayed

$1.1B

Mkt cap

$992.0M

Q2 FY26$583M

Revenue

$411MQ3 FY26

FY25$2.2B

Revenue

$1.6BFY25

ENOV19.98vsIART12.74Pre-marketOct 30 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ENOV, solidIART, dashed

Supply-chain overlap

Revenue flow

ENOV: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: ENOV, IART.

Role chip = supplier or customerSource: SEC EDGAR